Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations.

Starczynowski DT, Morin R, McPherson A, Lam J, Chari R, Wegrzyn J, Kuchenbauer F, Hirst M, Tohyama K, Humphries RK, Lam WL, Marra M, Karsan A.

Blood. 2011 Jan 13;117(2):595-607. doi: 10.1182/blood-2010-03-277012. Epub 2010 Oct 20.

2.

Genomic analysis of acute leukemia.

Mullighan CG.

Int J Lab Hematol. 2009 Aug;31(4):384-97. doi: 10.1111/j.1751-553X.2009.01167.x. Epub 2009 May 18. Review.

PMID:
19486196
3.

Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes.

Jacoby MA, Walter MJ.

Expert Rev Mol Diagn. 2012 Apr;12(3):253-64. doi: 10.1586/erm.12.18. Review.

PMID:
22468816
4.

Potential therapeutic applications of miRNA-based technology in hematological malignancies.

Barbarotto E, Calin GA.

Curr Pharm Des. 2008;14(21):2040-50. Review.

PMID:
18691114
5.

Copy number alterations and expression profiles of candidate genes in a pulmonary inflammatory myofibroblastic tumor.

Jung SH, Yim SH, Hu HJ, Jung CK, Lee SH, Kim DH, Chung YJ.

Lung Cancer. 2010 Nov;70(2):152-7. doi: 10.1016/j.lungcan.2010.01.019. Epub 2010 Feb 24. Review.

PMID:
20185201
6.

microRNAs as oncogenes and tumor suppressors.

Zhang B, Pan X, Cobb GP, Anderson TA.

Dev Biol. 2007 Feb 1;302(1):1-12. Epub 2006 Aug 16. Review.

7.

Epigenetic regulation of miRNA genes in acute leukemia.

Agirre X, Martínez-Climent JÁ, Odero MD, Prósper F.

Leukemia. 2012 Mar;26(3):395-403. doi: 10.1038/leu.2011.344. Epub 2011 Dec 6. Review.

PMID:
22143672
8.

MicroRNAs in acute leukemia: from biological players to clinical contributors.

Schotte D, Pieters R, Den Boer ML.

Leukemia. 2012 Jan;26(1):1-12. doi: 10.1038/leu.2011.151. Epub 2011 Jun 24. Review.

PMID:
21701489
9.

MicroRNAs in myeloid malignancies.

Gordon JE, Wong JJ, Rasko JE.

Br J Haematol. 2013 Jul;162(2):162-76. doi: 10.1111/bjh.12364. Epub 2013 May 16. Review.

PMID:
23679825
10.

microRNAs in acute myeloid leukemia: expression patterns, correlations with genetic and clinical parameters, and prognostic significance.

Wieser R, Scheideler M, Hackl H, Engelmann M, Schneckenleithner C, Hiden K, Papak C, Trajanoski Z, Sill H, Fonatsch C.

Genes Chromosomes Cancer. 2010 Mar;49(3):193-203. doi: 10.1002/gcc.20740. Review.

PMID:
20013895
11.

Genomic analysis of acute myeloid leukemia: potential for new prognostic indicators.

Eklund EA.

Curr Opin Hematol. 2010 Mar;17(2):75-8. doi: 10.1097/MOH.0b013e3283366c43. Review.

12.

Hematological malignancies: role of miRNAs and their in silico aspects.

Omer A, Yadav NK, Singh P, Singh RK.

Expert Rev Anticancer Ther. 2013 Sep;13(9):1121-33. doi: 10.1586/14737140.2013.833683. Review.

PMID:
24053209
13.

Clinical significance of microRNAs in chronic and acute human leukemia.

Yeh CH, Moles R, Nicot C.

Mol Cancer. 2016 May 14;15(1):37. doi: 10.1186/s12943-016-0518-2. Review.

14.

Pathogenic microRNA's in myeloid malignancies.

Khalaj M, Tavakkoli M, Stranahan AW, Park CY.

Front Genet. 2014 Nov 19;5:361. doi: 10.3389/fgene.2014.00361. eCollection 2014. Review.

15.

MicroRNAs: new players in acute myeloid leukaemia.

Havelange V, Garzon R, Croce CM.

Br J Cancer. 2009 Sep 1;101(5):743-8. doi: 10.1038/sj.bjc.6605232. Epub 2009 Aug 11. Review.

16.

microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview.

Gabra MM, Salmena L.

Front Oncol. 2017 Oct 30;7:255. doi: 10.3389/fonc.2017.00255. eCollection 2017. Review.

Supplemental Content

Support Center